(Q33436688)

English

Phase II trial of outpatient interleukin-2 in malignant lymphoma, chronic lymphocytic leukemia, and selected solid tumors

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

26 July 2017

Phase II trial of outpatient interleukin-2 in malignant lymphoma, chronic lymphocytic leukemia, and selected solid tumors (English)

1 reference

stated in

Europe PubMed Central

26 July 2017

phase II clinical trial

0 references

0 references

1 reference

chronic lymphocytic leukemia

1 reference

M A Allison

1

1 reference

stated in

Europe PubMed Central

PubMed ID

2783339

retrieved

26 July 2017

S E Jones

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

2783339

retrieved

26 July 2017

P McGuffey

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed ID

2783339

retrieved

26 July 2017

language of work or name

English

0 references

publication date

1 January 1989

1 reference

stated in

Europe PubMed Central

26 July 2017

Journal of Clinical Oncology

1 reference

stated in

Europe PubMed Central

26 July 2017

7

1 reference

stated in

Europe PubMed Central

26 July 2017

1

1 reference

stated in

Europe PubMed Central

26 July 2017

75-80

1 reference

stated in

Europe PubMed Central

PubMed ID

2783339

retrieved

26 July 2017

Identifiers

DOI

10.1200/JCO.1989.7.1.75

1 reference

stated in

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

PubMed ID

2783339

retrieved

26 July 2017

(Q33436688)

Phase II trial of outpatient interleukin-2 in malignant lymphoma, chronic lymphocytic leukemia, and selected solid tumors

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)